Ugur Sahin Sells $8.44M of BioNTech SE (BNTX) — SEC Form 4, Sep 14, 2026

Open-Market Net Sale · SEC Form 4
−$8,439,336
10b5-1 Plan

Equity position changed by -0.2%

Reporting Owner
Ugur Sahin
CEO 10% Owner
TXN 2026-09-14 · FILED 2026-09-14
Equity Position 39.8M sh 39,906,320 → 39,820,320
Equity Change -0.2% shares held after vs before
Filing Lag 0 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

BioNTech SE

BNTX CIK 0001776985
All BioNTech SE insider activity
Filing Date
2026-09-14
Report Date
2026-09-14
Accession No.
0002123975-26-000015
Accepted At
2026-09-14 20:50 UTC
Reporting Owner
Name Relationship
Ugur Sahin CIK 0002123975
CEO 10% Owner
Ugur Sahin at BioNTech SE Full insider history
Bought (12 mo) —
Sold (12 mo) $84,232,245
More from this insider at BioNTech SE
2026-10-09 Sell -$5,945,855 View
2026-10-07 Sell -$2,300,633 View
2026-10-06 Sell -$9,033,642 View
2026-10-02 Sell -$3,301,069 View
2026-09-30 Sell -$6,480,659 View
All filings by this insider at BioNTech SE
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Ordinary Shares 2026-09-11 S - Sale 10b5-1 45,000 D $96.93 -$4,362,021 643,209 Direct
Ordinary Shares 2026-09-14 S - Sale 10b5-1 41,000 D $99.45 -$4,077,315 602,209 Direct
Non-Derivative Holdings
Title Shares Held Ownership
Ordinary SharesF1 39,218,111 Indirect See Footnote
Footnotes (1)
F1
The ordinary shares are held by Medine GmbH. The reporting person is the sole shareholder of Medine GmbH. 106,721 of the ordinary shares noted herein are held for the benefit of an individual under a trust arrangement, pursuant to which Medine GmbH exercises voting power, but not dispositive power, over such ordinary shares for so long as such ordinary shares are held in trust. The reporting person may be deemed to beneficially own the ordinary shares held by Medine GmbH. Show more
Remarks

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on June 3, 2026.

Show more

Related filings at BioNTech SE

Institutional Holders
13F holders · Jun 30, 2026 284 institutional managers reporting a position
Largest by reported value
  1. Fmr Llc $705M
  2. Primecap Management Co/Ca/ $351M
  3. Dodge & Cox $342M
5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at BioNTech SE
All BioNTech SE insider activity
GET /v1/forms/4/0002123975-26-000015 API docs
View Original SEC Filing